inside a pharmaceutical Goliath. This would require a radical shake-up. Pfizer became even bigger when it acquired rival Wyeth for $68 billion in January. But Goodman remains persuaded that Pfizer has no better option than to conduct research in smaller...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Interactive Case Study: Pfizer's More Effective Pharma Research
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account